J. Lechner-Scott

发表

Defining secondary progressive multiple sclerosis.

Pierre Grammond, Patrizia Sola, Katherine Buzzard, 2016, Brain : a journal of neurology.

A Transcription Factor Map as Revealed by a Genome-Wide Gene Expression Analysis of Whole-Blood mRNA Transcriptome in Multiple Sclerosis

Mario Inostroza-Ponta, Regina Berretta, Pablo Moscato, 2010, PloS one.

Long COVID or post COVID-19 syndrome

G. Giovannoni, J. Lechner-Scott, M. Levy, 2021, Multiple Sclerosis and Related Disorders.

Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelination

S. Broadley, A. Ponsonby, L. Blizzard, 2022, Multiple sclerosis.

EBV as the "gluten of MS" hypothesis provides a rationale for trialing antiviral therapies.

G. Giovannoni, J. Lechner-Scott, A. Yeh, 2022, Multiple sclerosis and related disorders.

Associations between diet quality and depression, anxiety, and fatigue in multiple sclerosis.

L. Blizzard, A. Ponsonby, I. van der Mei, 2022, Multiple sclerosis and related disorders.

The future of microbiome research in neuroinflammatory disorders.

E. Waubant, G. Giovannoni, H. Tremlett, 2020, Multiple sclerosis and related disorders.

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination

S. Broadley, A. Kermode, D. Wakefield, 2019, Acta Neuropathologica Communications.

The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis.

D. Darby, T. Kilpatrick, H. Butzkueven, 2020, Multiple sclerosis and related disorders.

Favourable Outcome in a 33-Year-Old Female with Acute Haemorrhagic Leukoencephalitis

J. Lechner-Scott, E. Sugo, Sophie E Waller, 2017, Case Reports in Neurology.

Is the incidence of multiple sclerosis really increasing?

G. Giovannoni, J. Lechner-Scott, M. Levy, 2020, Multiple sclerosis and related disorders.

Acute flaccid myelitis in the 21st century: reminiscence of poliomyelitis or a new emergent disease.

E. Waubant, G. Giovannoni, J. Lechner-Scott, 2019, Multiple sclerosis and related disorders.

Long-term dietary acid load is associated with depression in multiple sclerosis, but less evidence was found with fatigue and anxiety.

J. Lechner-Scott, Ponsonby Al, A. Saul, 2022, Multiple sclerosis and related disorders.

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination

S. Broadley, C. Fraser, M. Barnett, 2019, Acta Neuropathologica Communications.

Uveitis and optic perineuritis in the context of myelin oligodendrocyte glycoprotein antibody seropositivity

C. Fraser, R. Dale, S. Ramanathan, 2019, European journal of neurology.

Melatonin and multiple sclerosis.

G. Giovannoni, J. Lechner-Scott, M. Levy, 2021, Multiple sclerosis and related disorders.

Genetic variants are major determinants of cerebrospinal fluid antibody levels in multiple sclerosis

Liberatore, Ingrid, Finn, 2015 .

Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20

Pablo Moscato, Rodney J. Scott, Brian L. Browning, 2009, Nature Genetics.

Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study

X. Montalban, J. Lechner-Scott, M. Slee, 2016, The Pharmacogenomics Journal.

Multiple sclerosis and migration revisited.

E. Waubant, G. Giovannoni, J. Lechner-Scott, 2019, Multiple sclerosis and related disorders.

Computer assisted retraining of attentional impairments in patients with multiple sclerosis

S. Huber, W. Ammann, L. Kappos, 1998, Journal of neurology, neurosurgery, and psychiatry.

Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis

M. Slee, M. Trojano, F. Grand'Maison, 2018, JAMA neurology.

The biological rabbit hole: Only for the blind.

G. Giovannoni, J. Lechner-Scott, M. Levy, 2022, Multiple sclerosis and related disorders.

ONSET OF MULTIPLE SCLEROSIS IS PREVENTABLE - TIME TO ACT NOW!

G. Giovannoni, J. Lechner-Scott, A. Yeh, 2022, Multiple sclerosis and related disorders.

Diagnosis of multiple sclerosis: Progress or confusion?

G. Giovannoni, J. Lechner-Scott, A. Yeh, 2022, Multiple sclerosis and related disorders.

Is multiple sclerosis overdiagnosed?

G. Giovannoni, D. Pohl, J. Lechner-Scott, 2021, Multiple sclerosis and related disorders.

Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS

Pierre Grammond, Patrizia Sola, Murat Terzi, 2017, Neurology.

Saliva-derived DNA performs well in large-scale, high-density SNP microarray studies

Marilyn, Merriman, Booth, 2017 .

Migraine and multiple sclerosis: The final answer?

G. Giovannoni, J. Lechner-Scott, M. Levy, 2023, Multiple sclerosis and related disorders.

A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort study

S. Broadley, A. Ponsonby, L. Blizzard, 2023, Multiple sclerosis.

Higher dietary quality is prospectively associated with lower MRI FLAIR lesion volume, but not with hazard of relapse, change in disability or black hole volume in people with Multiple Sclerosis.

L. Blizzard, A. Ponsonby, J. Lechner-Scott, 2023, Multiple Sclerosis and Related Disorders.

IS MULTIPLE SCLEROSIS A GLYMPHATICOPATHY?

J. Lechner-Scott, M. Levy, C. Hawkes, 2023, Multiple Sclerosis and Related Disorders.

Why should Neurologists get involved in family planning?

G. Giovannoni, J. Lechner-Scott, M. Levy, 2020, Multiple sclerosis and related disorders.